World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
62
Citations
16846
World Ranking
3108
National Ranking
1455

William Stohl publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where William Stohl sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 188 publications — 30th percentile

30% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

William Stohl D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where William Stohl sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 62 D-Index — 37th percentile

37% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

William Stohl is affiliated with the University of Southern California in the United States. Their research primarily spans the fields of Medicine and Immunology and Microbiology, with a focus on specific subfields including Immunology, Rheumatology, Radiology, Nuclear Medicine and Imaging, Genetics, and Pathology and Forensic Medicine.

The main topics of Stohl's work are thorough and specialized, covering Systemic Lupus Erythematosus Research, T-cell and B-cell Immunology, Monoclonal and Polyclonal Antibodies Research, Chronic Lymphocytic Leukemia Research, Immune Cell Function and Interaction, Atherosclerosis and Cardiovascular Diseases, and Lymphoma Diagnosis and Treatment.

Stohl has published extensively in various scientific venues. Frequent publication venues include:

  • Annals of the Rheumatic Diseases
  • ACR Open Rheumatology
  • The Lancet Rheumatology
  • The Journal of Immunology
  • American Journal of Reproductive Immunology

Their recent papers illustrate a focus on autoimmune diseases and therapeutic approaches, notably in systemic lupus erythematosus and rheumatoid arthritis. Selected recent papers by Stohl include:

  • Filgotinib in combination with methotrexate or as monotherapy versus methotrexate monotherapy in patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: the phase 3, randomised controlled FINCH 3 trial (2021, Annals of the Rheumatic Diseases)
  • Belimumab and Rituximab in Systemic Lupus Erythematosus: A Tale of Two B Cell-Targeting Agents (2020, Frontiers in Medicine)
  • Mortality and adverse events of special interest with intravenous belimumab for adults with active, autoantibody-positive systemic lupus erythematosus (BASE): a multicentre, double-blind, randomised, placebo-controlled, phase 4 trial (2020, The Lancet Rheumatology)
  • Systemic lupus erythematosus (SLE): emerging therapeutic targets (2020, Expert Opinion on Therapeutic Targets)
  • Impact of Belimumab on Organ Damage in Systemic Lupus Erythematosus (2022, Arthritis Care & Research)

Collaborations form an integral part of Stohl's research. Frequent coauthors include:

  • Leanna Wise
  • David A. Roth
  • Ning Yu
  • James Cheng-Chung Wei
  • Julia Harris

Best Publications

  • A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus

    Richard Furie;Michelle Petri;Omid Zamani;Ricard Cervera

  • Elevated serum B lymphocyte stimulator levels in patients with systemic immune–based rheumatic diseases

    Gurtej S. Cheema;Viktor Roschke;David M. Hilbert;William Stohl

  • B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations.

    William Stohl;Samy Metyas;Soon Min Tan;Gurtej S. Cheema

  • A Phase II, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of Belimumab in Patients With Active Systemic Lupus Erythematosus

    Daniel J. Wallace;William Stohl;Richard A. Furie;Jeffrey R. Lisse

  • Association of Plasma B Lymphocyte Stimulator Levels and Disease Activity in Systemic Lupus Erythematosus

    Michelle Petri;William Stohl;Winn Chatham;W. Joseph McCune

  • Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial

    Roy Fleischmann;Eduardo Mysler;Stephen Hall;Alan J Kivitz

  • Novel Evidence-Based Systemic Lupus Erythematosus Responder Index

    Richard A. Furie;Michelle A. Petri;Daniel J. Wallace;Ellen M. Ginzler

  • Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus.

    William Stohl;Falk Hiepe;Kevin M. Latinis;Mathew Thomas

  • TGF-β Requires CTLA-4 Early after T Cell Activation to Induce FoxP3 and Generate Adaptive CD4+CD25+ Regulatory Cells

    Song Guo Zheng;Ju Hua Wang;William Stohl;Kyoung Soo Kim

  • Efficacy and Safety of Subcutaneous Belimumab in Systemic Lupus Erythematosus: A Fifty-Two-Week Randomized, Double-Blind, Placebo-Controlled Study.

    William Stohl;Andreas Schwarting;Masato Okada;Morton Scheinberg

  • Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial

    P.P. Tak;W.F. Rigby;A. Rubbert-Roth;C.G. Peterfy

  • BLyS and APRIL form biologically active heterotrimers that are expressed in patients with systemic immune-based rheumatic diseases.

    Viktor Roschke;Svetlana Sosnovtseva;Christopher D. Ward;June S. Hong

  • Circulating levels of B lymphocyte stimulator in patients with rheumatoid arthritis following rituximab treatment: relationships with B cell depletion, circulating antibodies, and clinical relapse.

    Geraldine Cambridge;William Stohl;Maria J. Leandro;Thi-Sau Migone

  • Biologic activity and safety of belimumab, a neutralizing anti-B-lymphocyte stimulator (BLyS) monoclonal antibody: a phase I trial in patients with systemic lupus erythematosus

    Richard Furie;William Stohl;Ellen M Ginzler;Michael Becker

  • Local production of B lymphocyte stimulator protein and APRIL in arthritic joints of patients with inflammatory arthritis.

    Soon-Min Tan;Dong Xu;Viktor Roschke;James W. Perry

  • Efficacy and safety of subcutaneous tabalumab, a monoclonal antibody to B-cell activating factor, in patients with systemic lupus erythematosus: results from ILLUMINATE-2, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study

    J T Merrill;R F van Vollenhoven;J P Buyon;R A Furie

  • B cell depletion therapy in systemic lupus erythaematosus: relationships among serum B lymphocyte stimulator levels, autoantibody profile and clinical response

    Geraldine Cambridge;David A Isenberg;Jcw Edwards;Maria J Leandro

  • Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study.

    Noa Schwartz;Tamar Rubinstein;Linda C Burkly;Christopher E Collins;Christopher E Collins

  • Disease Control and Safety of Belimumab Plus Standard Therapy Over 7 Years in Patients with Systemic Lupus Erythematosus

    Ellen M. Ginzler;Daniel J. Wallace;Joan T. Merrill;Richard A. Furie

  • B lymphocyte stimulator (BLyS) isoforms in systemic lupus erythematosus: disease activity correlates better with blood leukocyte BLyS mRNA levels than with plasma BLyS protein levels

    Christopher E Collins;Amanda L Gavin;Thi-Sau Migone;David M Hilbert

Frequent Co-Authors

Chaim Putterman
Chaim Putterman Albert Einstein College of Medicine
Chaim O. Jacob
Chaim O. Jacob University of Southern California
Michael P. Cancro
Michael P. Cancro University of Pennsylvania
David M. Roth
David M. Roth University of California San Diego
Joan T. Merrill
Joan T. Merrill Oklahoma Medical Research Foundation
Daniel J. Wallace
Daniel J. Wallace Cedars-Sinai Medical Center
Song Guo Zheng
Song Guo Zheng Shanghai Jiao Tong University
David A. Horwitz
David A. Horwitz University of Southern California
Michael Koss
Michael Koss ETH Zurich
Michelle Petri
Michelle Petri Johns Hopkins University School of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students pursuing immunology, understanding related healthcare degrees can open diverse career opportunities. Many professionals transition into fields requiring advanced nursing skills, such as becoming a Nurse Practitioner. Enrolling in a nurse practitioner accelerated program can fast-track this process for those with prior healthcare experience.

For registered nurses seeking specialization, obtaining an acute care NP certification expands opportunities to care for critically ill patients, which aligns well with immunological expertise.

Those new to nursing may consider starting with online ADN programs for non nurses. Such programs provide a foundational pathway into nursing, enabling further advancement into immunology-related roles.

Career prospects also vary by location and degree level. A Doctor of Nursing Practice (DNP) degree often leads to higher salaries and leadership roles. For detailed regional salary insights, see the doctor of nursing practice salary overview.

Best Scientists Citing William Stohl

Trending Scientists

Recently Published Articles